We develop complex injectables addressing two markets: 1) Off-Exclusivity (generic) therapies exhibiting limited competition, sustained high pricing and supply risk - this is often the case where API, formulation, or manufacturing challenges exist, or within opaque product markets; 2) Branded Reformulations, long-acting, for existing chronic disease therapies benefiting patients through increased adherence and administration convenience.